Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 21, 2022Frontiers in OncologyOpen Access

Patient-Derived Extracellular Vesicles Proteins as New Biomarkers in Multiple Myeloma - A Real-World Study

View Full Paper
Ask AI
Bookmark
Share

Authors

BFBruna FerreiraChampalimaud FoundationECEmilie Arnault CarneiroChampalimaud FoundationCPCarolina PestanaChampalimaud Foundation

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ferreira et al. (2022) studied this question.

synapsesocial.com/papers/6a1a97c8382248a45185a290https://doi.org/10.3389/fonc.2022.860849
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma2016 · 106 citations
  2. 2A novel community driven software for functional enrichment analysis of extracellular vesicles data2017 · 371 citations
  3. 3Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing2017 · 434 citations
  4. 4Functions of ERp57 in the Folding and Assembly of Major Histocompatibility Complex Class I Molecules2006 · 76 citations
  5. 5Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma2009 · 77 citations